Position in CBLL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,452,010
-$2,082,188 QoQ
Shares Held
280,309
-31.8% QoQ
Ownership
0.730%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 123 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CBLL Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $6,797,922,248 across 98 Medical Devices names. CBLL ranks #51 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
16,760,070 | $1,520,808,749 | |
| 2 | SYK |
Stryker Corp
|
2,783,782 | $876,445,924 | |
| 3 | BSX |
Boston Scientific Corp
|
16,954,342 | $723,611,313 | |
| 4 | MDT |
Medtronic plc
|
9,012,210 | $705,025,184 | |
| 5 | EW |
Edwards Lifesciences Corp
|
4,549,113 | $411,512,760 | |
| 6 | STE |
STERIS plc
|
1,363,145 | $287,037,441 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
4,446,565 | $284,624,625 | |
| 8 | PEN |
Penumbra Inc
|
847,104 | $267,473,087 |
All Filings in CBLL
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,452,010 | 280,309 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $7,534,198 | 411,031 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $7,125,407 | 324,916 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $121,702 | 10,592 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $189,809 | 10,134 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $406,041 | 21,137 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $1,682,251 | 65,002 | Shares | Defined | 2025-02-11 | |
| No filing history on record for this holder in this stock. | ||||||